TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 NOK)
Closing information | 2023/06 | 2021/12 | 2020/12 |
Turnover |
430,479
|
237,847
|
236,598 |
Financial expenses |
1,398
|
720
|
104 |
Earnings before taxes |
7,773
|
6,986
|
6,006 |
EBITDA |
9,427
|
7,893
|
6,346 |
Total assets |
246,431
|
257,995
|
229,586 |
Current assets |
246,161
|
257,451
|
228,789 |
Current liabilities |
86,301
|
105,892
|
185,647 |
Equity capital |
46,229
|
39,953
|
37,549 |
- share capital |
198
|
195
|
210 |
Employees (average) |
46
|
40
|
38 |
Financial ratios
Fiscal year | 2023/06 | 2021/12 | 2020/12 |
Solvency |
18.8%
|
15.5%
|
16.4% |
Turnover per employee |
9,358
|
5,946
|
6,226 |
Profit as a percentage of turnover |
1.8%
|
2.9%
|
2.5% |
Return on assets (ROA) |
3.7%
|
3.0%
|
2.7% |
Current ratio |
285.2%
|
243.1%
|
123.2% |
Return on equity (ROE) |
16.8%
|
17.5%
|
16.0% |
Change turnover |
188,920
|
17,596
|
11,564 |
Change turnover % |
78%
|
8%
|
5% |
Chg. No. of employees |
6
|
2
|
3 |
Chg. No. of employees % |
15%
|
5%
|
9% |
Total value of public sale
Fiscal year | 2023/06 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.